Compare Quest Diagnostics Inc (DGX) vs Freeport-McMoRan Inc (FCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Freeport-McMoRan Inc — how do they compare? Quest Diagnostics Inc trades at $202.3 (market cap $22.80B), while Freeport-McMoRan Inc trades at $60.46 (market cap $89.06B). The key difference: Freeport-McMoRan Inc is far larger — about 3.9× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.67%). Which is the better fit depends on your goals.
| DGX | FCX | |
|---|---|---|
Market Cap | $22.80B | $89.06B |
Sector | Health | Basic Materials |
52-Week High | $216.02 | $71.73 |
52-Week Low | $166.45 | $35.34 |
Enterprise Value | $28.82B | $95.72B |
Dividend Yield | 1.67% | 0.97% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →
